+129.1%
ASML vs BBIO
+44.0%
+85.1%
-22.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +4.2% | -0.8% | +4.9% | +4.4% |
| 7D | +1.1% | -2.3% | +3.4% | +1.7% |
| 30D | +2.2% | -8.7% | +10.9% | +4.3% |
| 3M | -2.3% | +11.2% | -13.5% | -5.6% |
| 6M | +23.0% | +12.5% | +10.5% | +18.9% |
| YTD | +61.1% | -2.2% | +63.2% | +58.2% |
| 1Y | +129.1% | +44.4% | +84.7% | +103.7% |
| All | +129.1% | +44.0% | +85.1% | +103.7% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling